Healthcare
Sundrug Co.,Ltd.(SDGCF)
Live Price
Offline$28.18
+0.00% today
1Y Change
+0.00%
Window
Jun 20, 2025 → Jun 16, 2026
- Market Cap
- $440.32B
- Revenue Growth
- +6.7%
- EPS Growth
- +5.6%
- Dividend Yield
- 3.5%
Coverage: 253 bars · Jun 20, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sundrug Co.,Ltd. (SDGCF) is a Healthcare stock with a market cap of $440.32B and listed on OTC. The stock last traded around $28.18 and up 0.0% across the available one-year price window (Jun 20, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of +6.7%, EPS growth of +5.6%, a dividend yield of 3.5%. What stands out right now is revenue +6.7%, EPS +5.6%, free cash flow +132.8% with operating margin 5.5% and ROIC 9.3%. The dividend matters to the case here, with a current yield around 3.5%. Valuation is more restrained than many high-expectation growth names at P/E 14.1 and price/sales 0.5. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines SDGCF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+6.7% vs +7.6% peer median
Operating Margin
Below sector median
+5.5% vs +19.4% peer median
P/E
Below sector median
14.1 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating story is still moving forward
Revenue is running at +6.7% and EPS at +5.6%, with operating margin around 5.5%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 3.5%, which matters if the thesis depends on income as much as growth.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SDGCF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SDGCF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SDGCF and SPY.
Company Overview
Sundrug Co.,Ltd.
Other OTC
Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. It also operates discount stores that offers food, cosmetics, home appliances, clothing, car supplies, sports and goods, alcoholic beverages, and pharmaceutical products, as well as fresh food, kerosene, etc. The company was founded in 1957 and is headquartered in Fuchu, Japan.
- Leadership
- Hiroshi Sadakata
- IPO Date
- Oct 24, 2014
- Employees
- 6.7k
- Street Address
- 1-38-1, Wakamatsucho
- Mailing
- Fuchu, 183-0005
- Region
- Fuchu, JP
- Reporting Currency
- USD
- Investor Line
- 81 4 2369 6211
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 14.1
- EV/EBITDA
- 6.5
- Price/Sales
- 0.5
- Price/Book
- 1.6
Growth
- Revenue
- +6.7%
- EPS
- +5.6%
- Free Cash Flow
- +132.8%
Profitability
- Gross Margin
- 25.0%
- Operating Margin
- 5.5%
- Net Margin
- 3.7%
- ROE
- 11.4%
- ROIC
- 9.3%
Balance Sheet
- Debt/Equity
- 0.18
- Current Ratio
- 1.72
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.